| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
VP Strat &Investor Relations | VP Corp Development &Strategy
1 company
Lai Quintin J serves as a VP Strat &Investor Relations at WST. Across recent SEC filings that breaks down to 0 buys and 14 sells. Those positions are worth an estimated $1.5M at current prices.
Historically, Lai Quintin J's trades have earned a middling insider score of 68/100 across 3 rated trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +23.2%.
The biggest single holding is WST (~$1.5M) as VP Strat &Investor Relations. The recent filings there lean toward selling, a net 38,789 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 11, 2023 | WST West Pharmaceutical Services Inc | VP Strat &Investor Relations | Sale+OE | 21,101 | $395.12 | $8,337,486.81 | -23.9% | -14.8% | -27.0% | |
| Mar 14, 2022 | WST West Pharmaceutical Services Inc | VP Corp Development &Strategy | Sale+OE | 8,016 | $371.69 | $2,979,491.70 | -9.9% | -23.2% | -11.0% | |
| Sep 10, 2021 | WST West Pharmaceutical Services Inc | VP Corp Development &Strategy | Sale+OE | 9,672 | $460.76 | $4,456,451.51 | -43.0% | -6.5% | -31.6% |